HAEMONETICS CORP
HAE—
HAEMONETICS CORPHAE$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$2.05
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$1.33B
Net income
$97.31M
Net margin
7.3%
Gross margin
59.0%
Dividends & financials
HAEMONETICS CORP (HAE) reported revenue of $1.33B and net income of $97.31M, or $2.05 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.